(Q39255203)

10 September 2017

title

The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture (English)

1 reference

10 September 2017

Alexander Hoh

1

1 reference

10 September 2017

Alexander Dewerth

2

1 reference

10 September 2017

Fabian Vogt

3

1 reference

10 September 2017

Julia Wenz

4

1 reference

10 September 2017

Patrick A Baeuerle

5

1 reference

10 September 2017

Steven W Warmann

6

1 reference

10 September 2017

Joerg Fuchs

7

1 reference

10 September 2017

Sorin Armeanu-Ebinger

8

1 reference

10 September 2017

publication date

22 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

33

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

127-136

1 reference

Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group

10 September 2017

cites work

1 reference

Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study

21 January 2018

1 reference

Primary hepatic tumors of childhood

21 January 2018

1 reference

Surgical treatment of hepatoblastoma in children

21 January 2018

1 reference

Hepatocellular carcinoma in children: clinical review and comparison with adult cases

21 January 2018

1 reference

21 January 2018

Liver tumors in children

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Hepatoblastoma: recent developments in research and treatment

21 January 2018

1 reference

Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

21 January 2018

1 reference

Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy

21 January 2018

1 reference

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection.

21 January 2018

1 reference

Recognition of nonpeptide prenyl pyrophosphate antigens by human gammadelta T cells

21 January 2018

1 reference

Activation of V gamma 9V delta 2 T cells by NKG2D.

21 January 2018

1 reference

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.

21 January 2018

1 reference

Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma

21 January 2018

1 reference

Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells

21 January 2018

1 reference

Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells

21 January 2018

1 reference

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

21 January 2018

1 reference

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma in children.

21 January 2018

1 reference

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation

21 January 2018

1 reference

Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma

21 January 2018

1 reference

Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110.

21 January 2018

1 reference

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review

21 January 2018

1 reference

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

21 January 2018

1 reference

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.

21 January 2018

1 reference

V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab

21 January 2018

1 reference

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

21 January 2018

1 reference

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours

21 January 2018

1 reference

γδ T-cell immunotherapy for lung cancer.

21 January 2018

1 reference

Granulysin‐Dependent Killing of Intracellular and ExtracellularMycobacterium tuberculosisby Vγ9/Vδ2 T Lymphocytes

21 January 2018

1 reference

CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitro

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12011

1 reference

10 September 2017

1 reference